Get the Stockscreener App
3.87
0.26%
0.01
Pre-market:
3.76
-0.11
-2.84%
Cumberland Pharmaceuticals Inc stock is traded at $3.87, with a volume of 54,881.
It is up +0.26% in the last 24 hours and down -21.82% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$3.86
Open:
$3.86
24h Volume:
54,881
Relative Volume:
0.29
Market Cap:
$57.88M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-5.3014
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
-1.78%
1M Performance:
-21.82%
6M Performance:
+36.27%
1Y Performance:
-15.87%
1-Day Range:
$3.81
$3.92
1-Week Range:
$3.54
$3.98
52-Week Range:
$1.85
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.87 | 57.73M | 37.79M | -10.38M | -1.00M | -0.73 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Resistance Check: What is the dividend yield of Cumberland Pharmaceuticals IncGap Up & Verified Swing Trading Watchlist - baoquankhu1.vn
Little Excitement Around Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Revenues As Shares Take 31% Pounding - simplywall.st
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200-Day Moving AverageHere's Why - MarketBeat
FDA fast tracks Dyscorban for treating heart problems in Duchenne - Muscular Dystrophy News
Ideas Watch: Why is Cumberland Pharmaceuticals Inc stock going upEarnings Miss & Long Hold Capital Preservation Tips - baoquankhu1.vn
FDA fast tracks Cumberland’s DMD heart disease therapy By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals Wins Fast Track for Ifetroban - TipRanks
Cumberland Pharmaceuticals Receives FDA Fast Track Designation for DMD Therapy - TradingView
FDA fast tracks Cumberland’s DMD heart disease therapy - Investing.com
Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug - Investing.com Canada
Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program - Yahoo Finance
Aug Chart Watch: Is Cumberland Pharmaceuticals Inc stock good for income investorsQuarterly Market Summary & High Return Trade Opportunity Guides - baoquankhu1.vn
Critical Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) vs. Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Stock Market Recap: Is Cumberland Pharmaceuticals Inc stock good for income investors2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Will Cumberland Pharmaceuticals Inc announce a stock splitJuly 2025 Price Swings & Reliable Price Breakout Alerts - baoquankhu1.vn
Breakout Watch: How does Cumberland Pharmaceuticals Inc score in quality rankings2025 Momentum Check & Real-Time Price Movement Reports - baoquankhu1.vn
Can Cumberland Pharmaceuticals Inc. reach all time highs this yearTrade Risk Assessment & Smart Swing Trading Alerts - Mfd.ru
Take Profit: Is Cumberland Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Levels & Fast Entry and Exit Trade Plans - mfd.ru
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Aug Reactions: Can SAMG lead its sector in growthQuarterly Trade Review & Daily Technical Forecast Reports - baoquankhu1.vn
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2025 Earnings Call Transcript - MSN
Cumberland Pharmaceuticals (NASDAQ:CPIX) shareholders are still up 67% over 1 year despite pulling back 10% in the past week - simplywall.st
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
FOMO Trade: Is AVAV stock a good pick for beginnersJuly 2025 Rallies & Stock Portfolio Risk Management - baoquankhu1.vn
Targets Report: Can Cumberland Pharmaceuticals Inc beat the S P 5002025 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
Niche Focus & Regulation Shape the Future of Healthcare Firms - sharewise.com
Can Cumberland Pharmaceuticals Inc. stock beat market expectations this quarterTrade Volume Report & AI Forecast for Swing Trade Picks - ulpravda.ru
Zacks initiates coverage of CPIX with outperform recommendation - MSN
Cumberland Pharmaceuticals (NASDAQ:CPIX) Upgraded to Hold at Wall Street Zen - MarketBeat
What risks investors should watch in Cumberland Pharmaceuticals Inc. stockEarnings Summary Report & Safe Entry Momentum Stock Tips - Улправда
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Will Cumberland Pharmaceuticals Inc. stock deliver shareholder value2025 Support & Resistance & High Accuracy Investment Signals - Улправда
Is Cumberland Pharmaceuticals Inc. stock in correction or buying zone2025 Market Overview & Safe Capital Growth Stock Tips - ulpravda.ru
Is Cumberland Pharmaceuticals Inc. stock a safe buy before earnings2025 Technical Overview & Target Return Focused Picks - Улправда
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland reports progress in DMD heart disease trial - MSN
Is Cumberland Pharmaceuticals Inc. stock near bottom after declineTake Profit Strategies & Invest Like A Pro - Bollywood Helpline
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
What drives Cumberland Pharmaceuticals Inc stock priceExit Strategy Tips & Unlock Long-Term Capital Growth Ideas - earlytimes.in
With Cumberland Pharmaceuticals Stock Surging, Have You Considered The Downside? - Trefis
6-Day Rally Sends Cumberland Pharmaceuticals Stock Up 77% - Trefis
Is Cumberland Pharmaceuticals Inc. stock dividend yield sustainable2025 Market Sentiment & Weekly High Momentum Picks - Улправда
Top Research Reports for NVIDIA, Netflix & Merck - Yahoo Finance
Zacks Initiates Coverage of CPIX With Outperform Recommendation - sharewise.com
Cumberland Pharmaceuticals Stock On Fire: Up 76% With 5-Day Winning Streak - Trefis
Does Cumberland Pharmaceuticals Inc. stock trade at a discount to peers - Улправда
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):